Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) will issue its quarterly earnings data after the market closes on Monday, August 5th. Analysts expect the company to announce earnings of $0.10 per share for the quarter. Tactile Systems Technology has set its FY 2024 guidance at EPS.Individual interested in listening to the company’s earnings conference call can do so using this link.
Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) last released its quarterly earnings results on Monday, May 6th. The company reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.11) by $0.06. Tactile Systems Technology had a net margin of 10.19% and a return on equity of 15.88%. The business had revenue of $61.09 million for the quarter, compared to the consensus estimate of $59.10 million. On average, analysts expect Tactile Systems Technology to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Tactile Systems Technology Price Performance
Shares of Tactile Systems Technology stock opened at $12.26 on Friday. The company has a 50-day simple moving average of $12.09 and a two-hundred day simple moving average of $13.90. Tactile Systems Technology has a twelve month low of $9.69 and a twelve month high of $22.80. The stock has a market capitalization of $291.30 million, a price-to-earnings ratio of 10.22 and a beta of 1.18. The company has a quick ratio of 3.63, a current ratio of 4.26 and a debt-to-equity ratio of 0.13.
Insider Activity at Tactile Systems Technology
Analyst Ratings Changes
Separately, StockNews.com cut Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 18th.
Get Our Latest Research Report on Tactile Systems Technology
About Tactile Systems Technology
Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.
Featured Articles
- Five stocks we like better than Tactile Systems Technology
- Do ETFs Pay Dividends? What You Need to Know
- Hims & Hers Stock Falls on DexCom Fears: Analysts Predict Rally
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Snap’s Stock Plummets on Q2 Revenue Guidance Shortfall
- 3 Stocks to Consider Buying in October
- Intel Loses a Quarter of Its Value After Horrible Earnings Report
Receive News & Ratings for Tactile Systems Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology and related companies with MarketBeat.com's FREE daily email newsletter.